Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • November 24, 2015:

    Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE). The main component of the new method is a microarray platform. The target cells adhere to these structures while the remaining cells are simply washed away.Full Story

  • November 23, 2015:

    Philips’ new ultrasound digital health, called Lumify, connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services into a subscription-based program. Lumify helps health-care professionals make fast, informed diagnoses through a variety of scan types. scanning app allows users to examine the gall bladder, abdomen and lungs, in addition to having ob-gyn, vascular, superficial, musculoskeletal and soft tissue functionality while improving patient care and reducing costs.Full Story

  • November 18, 2015:

    Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial availability of the MyCareLink Smart Monitor, the world's first app-based remote monitoring system for patients with implantable pacemakers. With the MyCareLink Smart Monitor, patients with a Medtronic pacemaker can use their own smartphone or tablet technology, with cellular or Wi-Fi service, to securely transmit data from their pacemakers to their physicians, who can then interpret the data to make treatment decisions.Full Story

  • November 18, 2015:

    Evena Medical announced the launch of its Eyes-On Glasses 3.0, offering clinicians the first point-of-care wearable ultrasound system for deep tissue vascular imaging and the first device to deliver clear, anatomically accurate, real-time vascular imaging in a wearable, easy-to-use, hands-free and cart-free system. Full Story

  • November 16, 2015:

    A University of Arizona biomedical engineering doctoral student and, Researchers at the University of Arizona have invented a device called augmented microscopy that for the first time allows neurosurgeons, who use microscopes extensively while operating, to see blood flowing inside vessels and more clearly distinguish cancerous from healthy tissue under the microscope.Full Story

  • November 16, 2015:

    Cornell University biomedical engineers have developed specialized white blood cells - dubbed "super natural killer cells" - that seek out cancer cells in lymph nodes with only one purpose: destroy them. In the study, the biomedical engineers killed the cancerous tumor cells within days, by injecting liposomes armed with TRAIL (Tumor necrosis factor Related Apoptosis-Inducing Ligand) that attach to "natural killer" cells -- a type of white blood cell -- residing in the lymph nodes. This breakthrough halts the onset of metastasis, according to a new Cornell study published this month in the journal Biomaterials.Full Story

  • November 13, 2015:

    Breast cancer surgeons routinely face a dilemma: how to find tumors they cannot feel. Before going into the operating room they must use some method to locate them. A new antenna-like device made by Cianna Medical, Inc. and approved by the FDA helps surgeons find the breast cancer tumor and, because it leaves no protruding wires, like current techniques, it also makes surgery easier for women and their breast surgery team.Full Story

  • November 13, 2015:

    A Korean research team from the Bionano Center at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) conducted research to suppress an abnormal assembly of beta-amyloids, a protein commonly found in the brain that can cause Alzheimers, by using photo-excited porphyrins. Light-induced treatments using organic photosensitizers have advantages to managing the treatment in time and area..Full Story

  • November 10, 2015:

    Researchers at Washington University School of Medicine in St. Louis and the University of Illinois at Urbana-Champaign are building on wireless technology by developing flexible, implantable devices that can activate and, in theory, block pain signals in the body and spinal cord before those signals reach the brain.Full Story

  • November 5, 2015:

    Utah Valley University physicists are applying rocket science to the field of medical diagnostics. With a few key changes, the researchers used a noninvasive ultrasonic technique originally developed to detect microscopic flaws in solid fuel rockets, such as space shuttle boosters, to successfully detect cell stiffness changes associated with certain cancers and other diseases. Brian Patchett says “This method can be used to explore the aspect of cells that changes during Alzheimer’s disease, the metastasis of cancer, or during the onset of autoimmune responses to better understand these conditions and provide insight into possible treatment methods.”Full Story

  • November 4, 2015:

    Medtronic is conducting a large study to test the super Dimension navigation system which provides a minimally invasive approach to aid in the diagnosis of lung lesions and can be used to acquire ample tissue to enhance molecular genetic analysis/profiling of tumors for targeted therapy.Full Story

  • November 2, 2015:

    The discovery of markers measuring fatty acids by the University of Hawaii Cancer Center researchers may allow physicians to warn patients years before the onset of diabetes, therefore allowing them to change their lifestyle patterns potentially avoiding the diagnosis of a chronic disease.Full Story

  • November 2, 2015:

    Since the 1980s, Dr. Dennis Selkoe, Co-Director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital (BWH),have been gathering data to support the Amyloid Hypothesis, in which he proposed that Alzheimer’s disease begins with the build-up of amyloid beta protein in “thinking regions” of the brain.
    Currently, several pharmaceutical companies are developing treatments that use antibodies that target amyloid beta protein in the brain. Promising clinical trials of these antibodies suggest that an anti-amyloid treatment for Alzheimer’s disease may be available to patients within a few years.Full Story

  • October 29, 2015:

    A biodegradable Implant derived from cornstarch combined with a volcanic ash compound, Montmorillonite clay, could help heal the bones of hundreds of thousands of patients with orthopedic injuries who need bone replacement after tumor removal, spinal fusion surgery or fracture repair without the need for a second bone-harvesting procedure leading to fewer potential complications.Full Story

  • October 27, 2015:

    The U.S. Food and Drug Administration (FDA) has published draft guidance General Considerations for Animal Studies for Medical Devices. When finalized, the draft guidance is consistent with current Good Laboratory Practice requirements, but goes on to provide additional instructions outlining the recommended content, format, and organization of test protocols and reports, as well as considerations for the development and completion of the study.Full Story